Neurosurgical Management of Hypertonia in Children

Paul Steinbok

doi:10.1055/s-2002-35247

Seminars in Neurosurgery, Inhaltsverzeichnis

Seminars in Neurosurgery 2002; 13(1): 047-060
DOI: 10.1055/s-2002-35247

Neurosurgical Management of Hypertonia in Children

Paul Steinbok

Division of Pediatric Neurosurgery, Department of Surgery, University of British Columbia, Canada; and Division of Pediatric Neurosurgery, Section of Surgery, British Columbia's Children's Hospital, Vancouver, British Columbia, Canada

Abstract

ABSTRACT

Hypertonia, whether it is spasticity, dystonia or a combination, is an important clinical problem in children and is most commonly associated with cerebral palsy. In this review of the management of hypertonia in children with cerebral palsy, the multidisciplinary nature of the management is stressed. The various modalities of treatment are discussed, with the emphasis on the neurosurgical aspects of management. The two major neurosurgical treatments, namely selective dorsal rhizotomy and intrathecal baclofen, are reviewed in detail. Current knowledge about outcomes with these treatments is presented according to a paradigm developed by the National Center for Medical Rehabilitation Research. Guidelines are provided for the selection of the different treatment modalities.

KEYWORDS

Spasticity - dystonia - hypertonia - dorsal rhizotomy - intrathecal baclofen - cerebral palsy

Volltext

Referenzen

REFERENCES

1 Fahn S. Concept and classification of dystonia. Advances in Neurology . 1988; 50 1-8
2 Fahn S, Bressman S B, Marsden C D. Classification of Dystonia. In: Fahn S, Marsden CD, DeLong, M, eds. Dystonia 3 Vol 78. Philadelphia, PA: Lippincott-Raven, 1998: 1-10
3 Paneth N, Kiely J. The frequency of cerebral palsy: a review of population studies in industrialized nations since 1950. In: Stanley F, Alberman E, eds. The Epidemiology of the Cerebral Palsies London: Spastics International Medical Publications, 1984: 46-56
4 Stanley F J, Blair E. Why have we failed to reduce the incidence of cerebral palsy?. Medical Journal of Australia . 1991; 154 623-626
5 Newacheck P W, Taylor W R. Childhood chronic illness: prevalence, severity and impact. American Journal of Public Health . 1992; 82 364-371
6 Albright A L. Spasticity and movement disorders in cerebral palsy [editorial]. Journal of Child Neurology . 1996; 11 S1-4
7 Dabney K W, Lipton G E, Miller F. Cerebral palsy. Current Opinion in Pediatrics . 1997; 9 81-88
8 Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Developmental Medicine and Child Neurology . 2000; 42 816-824
9 Foerster O. On the indications and results of the excision of posterior spinal nerve roots in man. Surgery Gynecology and Obstetrics . 1913; 16 463-474
10 Gros C. Spasticity: clinical classification and surgical treatment. In: Krayenbujl H, ed. Advances and Technical Standards in Neurosurgery Vol 6. Wien: Springer-Verlag 1979: 55-97
11 Gros C, Ooaknine G, Vlahhovitch B, Frerebeau P. La radicotomie selective posterioeure dans le traitment neurochirurgical de l'hypertonie pyramidale. Neurochirurgie . 1967; 13 505-518
12 Privat J M, Benezech J, Frerebeau P, Gros C. Sectorial posterior rhizotomy, a new technique of surgical treatment for spasticity. Acta Neurochirurgica . 1976; 35 181-195
13 Fasano V A, Broggi G, Barolat-Romana G, Sguazzi A. Surgical treatment of spasticity in cerebral palsy. Childs Brain . 1978; 4 289-305
14 Fasano V A, Broggi G, Zeme S. Intraoperative electrical stimulation for functional posterior rhizotomy. Scandinavian Journal of Rehabilitation Medicine . 1988; 17(suppl) S149-S154
15 Fasano V A, Broggi G, Zeme S, Lo Russo G, Sguazzi A. Long-term results of posterior functional rhizotomy. Acta Neurochirurgica-Supplementum . 1980; 30 435-439
16 Peacock W J, Arens L J. Selective posterior rhizotomy for the relief of spasticity in cerebral palsy. South African Medical Journal . 1982; 62 119-124
17 Cohen A R, Webster H C. How selective is selective posterior rhizotomy?. Surgical Neurology . 1991; 35 267-272
18 Landau W M. Dorsal rhizotomy, a treatment of unproven efficacy. J Child Neurol . 1990; 5 174-178
19 Logigian E L, Wolinsky J S, Soriano S G, Madsen J R, Scott R M. H reflex studies in cerebral palsy patients undergoing partial dorsal rhizotomy. Muscle & Nerve . 1994; 17 539-549
20 Pollack M A. Limited benefit of electrophysiological studies during dorsal rhizotomy. Muscle & Nerve . 1994; 17 553-556
21 Steinbok P, Keyes R, Langill L, Cochrane D D. The validity of electrophysiological criteria used in selective functional posterior rhizotomy for treatment of spastic cerebral palsy. Journal of Neurosurgery . 1994; 81 354-361
22 Weiss I P, Schiff S J. Reflex variability in selective dorsal rhizotomy. Journal of Neurosurgery . 1993; 79 346-353
23 Steinbok P, Kestle J R. Variation between centers in electrophysiologic techniques used in lumbosacral selective dorsal rhizotomy for spastic cerebral palsy. Pediatric Neurosurgery . 1996; 25 233-239
24 Cochrane D D, Steinbok P. Laminotomy: a technical note. Childs Nervous System . 1992; 8 226-228
25 Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Child's Nervous System . 2001; 17 1-18
26 Sackett D L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest . 1986; 39 25-35
27 Bullock R, Chestnut R M, Clifton G. Guidelines for the management of severe head injury. Journal of Neurotrauma . 1996; 13 643-645
28 Wright F V, Sheil E M, Drake J M, Wedge J H, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Developmental Medicine & Child Neurology . 1998; 40 239-247
29 Hodgkinson I, Berard C, Jindrich M L, Sindou M, Mertens P, Berard J. Selective dorsal rhizotomy in children with cerebral palsy: results in 18 cases at one year postoperatively. Stereotactic & Functional Neurosurgery . 1997; 69 259-267
30 McLaughlin J F, Bjornson K F, Astley S J. The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series. Developmental Medicine & Child Neurology . 1994; 36 755-769
31 McLaughlin J F, Bjornson K F, Astley S J. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Developmental Medicine & Child Neurology . 1998; 40 220-232
32 Steinbok P, Reiner A M, Beauchamp R, Armstrong R W, Cochrane D D. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Developmental Medicine & Child Neurology . 1997; 39 178-184
33 McLaughlin J, Bjornson K, Temkin N. ``Selective'' dorsal rhizotomy: meta-analysis of three randomized controlled trials. Developmental Medicine and Child Neurology . 2002; 44 17-25
34 Bloom K K, Nazar G B. Functional assessment following selective posterior rhizotomy in spastic cerebral palsy. Childs Nervous System . 1994; 10 84-86
35 Dudgeon B J, Libby A K, McLaughlin J F, Hays R M, Bjornson K F, Roberts T S. Prospective measurement of functional changes after selective dorsal rhizotomy. Archives of Physical Medicine & Rehabilitation . 1994; 75 46-53
36 Loewen P, Steinbok P, Holsti L, MacKay M. Upper extremity performance and self-care skill changes with spastic cerebral palsy following selective posterior rhizotomy. Pediatric Neurosurgery . 1998; 29 191-198
37 Nishida T, Thatcher S W, Marty G R. Selective posterior rhizotomy for children with cerebral palsy: a 7-year experience. Childs Nervous System . 1995; 11 374-380
38 Craft S, Park T S, White D A, Schatz J, Noetzel M, Arnold S. Changes in cognitive performance in children with spastic diplegic cerebral palsy following selective dorsal rhizotomy. Pediatric Neurosurgery . 1995; 23 68-74
39 Arens L J, Peacock W J, Peter J. Selective posterior rhizotomy: a long-term follow-up study. Childs Nervous System . 1989; 5 148-152
40 Carroll K L, Moore K R, Stevens P M. Orthopedic procedures after rhizotomy. Journal of Pediatric Orthopedics . 1998; 18 69-74
41 Marty G R, Dias L S, Gaebler-Spira D. Selective posterior rhizotomy and soft-tissue procedures for the treatment of cerebral diplegia. Journal of Bone & Joint Surgery-American Volume . 1995; 77 713-718
42 Heim R C, Park T S, Vogler G P, Kaufman B A, Noetzel M J, Ortman M R. Changes in hip migration after selective dorsal rhizotomy for spastic quadriplegia in cerebral palsy. Journal of Neurosurgery . 1995; 82 567-571
43 Park T S, Vogler G P, Phillips II H L. Effects of selective dorsal rhizotomy for spastic diplegia on hip migration in cerebral palsy. Pediatric Neurosurgery . 1994; 20 43-49
44 Abbott R, Johann-Murphy M, Shiminski-Maher T. Selective dorsal rhizotomy: outcome and complications in treating spastic cerebral palsy. Neurosurgery . 1993; 33 851-857
45 Steinbok P, Schrag C. Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy. Pediatric Neurosurgery . 1998; 28 300-313
46 Deletis V, Vodusek D B, Abbott R, Epstein F J, Turndorf H. Intraoperative monitoring of the dorsal sacral roots: minimizing the risk of iatrogenic micturition disorders. Neurosurgery . 1992; 30 72-75
47 Abbott R. Complications with selective posterior rhizotomy. Pediatric Neurosurgery . 1992; 18 43-47
48 Abbott R, Forem S L, Johann M. Selective posterior rhizotomy for the treatment of spasticity: a review. Childs Nervous System . 1989; 5 337-346
49 Abbott R. Sensory rhizotomy for the treatment of childhood spasticity. Journal of Child Neurology . 1996; 11(suppl) S36-S42
50 Peter J C, Arens L J. Selective posterior lumbosacral rhizotomy for the management of cerebral palsy spasticity: a 10-year experience. South African Medical Journal . 1993; 83 745-747
51 Price G W, Wilkin G P, Turnbull M J, Bowery M G. Are baclofen-sensitive GABA_B receptors present on primary afferent terminals of the spinal cord?. Nature . 1984; 307 71-74
52 Knuttson E, Lindblom U, Beissinger R L, Martenson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paraparesis. Journal of Neurological Sciences . 1974; 23 473-484
53 Albright A L. Baclofen in the treatment of cerebral palsy. Journal of Child Neurology . 1996; 11 77-83
54 Van Hemert J CJ. A double blind comparison of baclofen and placebo in patients with spasticity of cerebral origin. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago: Yearbook Medical Publishers 1980: 41-50
55 Milla P J, Jackson A DM. A controlled trial of baclofen in children with cerebral palsy. Journal of International Medical Research . 1977; 5 398-404
56 O'Donnell M , Armstrong r . Pharmacologic interventions for management of spasticity in cerebral palsy. Mental Retardation and Developmental Disabilities Research Review . 1997; 3 204-211
57 Muller H , Zierski J , Dralle D , Kraus D , Mutschler E . Pharmacokinetics of intrathecal baclofen. In: Muller H, Zierski J, Penn RD, eds. Local Spinal Therapy of Spasticity. Berlin: Springer-Verlag 1988: 223-226
58 Kroin J S, Ali A , York M , Penn R D. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery . 1993; 33 226-230
59 Ochs G A. GA. Intrathecal baclofen. Baillieres Clinical Neurology . 1993; 2 73-86
60 Muller H , Zierski J , Dralle D , Hoffmann O , Michaelis G D. Intrathecal baclofen in spasticity. In: Muller H, Zierski J, Penn RD, eds. Local Spinal Therapy of Spasticity. Berlin: Springer-Verlag 1988: 155-214
61 Albright A L, Cervi A , Singletary J . Intrathecal baclofen for spasticity in cerebral palsy. Journal of the American Medical Association . 1991; 265 1418-1422
62 Bohannon R W, Smith M B. Interrater reliability of a modified Ashworth Scale. Physical Therapy . 1987; 67 206-207
63 Albright A L. Intrathecal baclofen in cerebral palsy movement disorders. Journal of Child Neurology . 1996; 11(suppl) S29-S35
64 Narayan R K, Loubser P G, Jankovic J , Donovan W H, Bontke C F. Intrathecal baclofen for intractable axial dystonia. Neurology . 1991; 41 1141-1142
65 Albright A L, Barry M J, Fasick P , Barron W , Shultz B . Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery . 1996; 38 934-939
66 Armstrong R W, Steinbok P , Cochrane D D, Kube S D, Fife S E, Farrell K . Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. Journal of Neurosurgery . 1997; 87 409-414
67 Akman M N, Loubser P G, Donovan W H, O'Neill M E, Rossi C D. Intrathecal baclofen: does tolerance occur?. Paraplegia . 1993; 31 516-520
68 Coffey R J, Cahill D , Steers W . Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. Journal of Neurosurgery . 1993; 78 226-232
69 Hugenholtz H , Nelson R F, Dehoux E , Bickerton R . Intrathecal baclofen for intractable spinal spasticity: a double-blind cross-over comparison with placebo in six patients. Canadian Journal of Neurological Sciences . 1992; 19 188-195
70 Loubser P , Narayan R K, Sandin K J, Donovan W H, Russell K D. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia . 1991; 29 48-64
71 Meythaler J M, Steers W D, Tuel S M, Cross L L, Haworth C S. Continuous intrathecal baclofen in spinal cord spasticity: a prospective study. American Journal of Physical Medicine & Rehabilitation . 1992; 71 321-327
72 Albright A L, Barron W B, Fasick M P, Polinko P , Janosky J . Continuous intrathecal baclofen infusion for spasticity of cerebral origin. Journal of the American Medical Association . 1993; 270 2475-2477
73 Albright A L, Barry M J, Hoffmann P . Intrathecal L-baclofen for cerebral spasticity: case report. Neurology . 1995; 45 2110-2111
74 Gerszten P C, Albright A L, Barry M J. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatric Neurosurgery . 1997; 27 40-44
75 Gerszten P C, Albright A L, Johnstone G F. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. Journal of Neurosurgery . 1998; 88 1009-1013
76 Gilmartin R , Rawlins P . Seizures in epileptic cerebral palsy patients receiving intrathecal baclofen infusion. Epilepsia . 1995; 36 S12
77 Krach L , Gilmartin R , Bruce D , Storrs B , Abbott R , Ward J . Functional changes noted following treatments of individuals with cerebral palsy with intrathecal baclofen. Developmental Medicine and Child Neurology . 1997; 39(suppl 75) S12-S13
78 Latash M L, Penn R D. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology. Physiotherapy Research International . 1996; 1 229-246
79 Penn R D, Gianino J M, York M M. Intrathecal baclofen for motor disorders. Movement Disorders . 1995; 10 675-677
80 Steinbok P D, Danesh H M, Evans D M, Kestle J R. Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatric Neurosurgery . 1995; 22 255-264
81 Almeida G L, Campbell S K, Girolami G L, Penn R D, Corcos D M. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen. Physical Therapy . 1997; 77 751-764
82 Gilmartin R , Bruce D , Storrs B B. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. Journal of Child Neurology . 2000; 15 71-77
83 Butler C , Campbell S . Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy.AACPDM Treatment Outcomes Committee Review Panel. Developmental Medicine & Child Neurology . 2000; 42 634-645
84 Ford B , Greene P , Louis E D. Use of intrathecal baclofen in the treatment of patients with dystonia. Archives of Neurology . 1996; 53 1241-1246
85 Albright A L, Barry M J, Painter M J, Shultz B . Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. Journal of Neurosurgery . 1998; 88 73-76
86 Penn R D. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. Journal of Neurosurgery . 1992; 77 236-240
87 Kofler M , Kronenberg M F, Rifici C , Saltuari L , Bauer G . Epileptic seizures associated with intrathecal baclofen application. Neurology . 1994; 44 25-27
88 Rifici C , Kofler M , Kronenberg M F, Kofler A , Bramanti P , Saltuari L . Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Functional Neurology . 1994; 9 29-34
89 Lazorthes Y , Sallerin-Caute B F, Verdie J C, Bastide R , Carillo J P. Chronic intrathecal baclofen administration for control of severe spasticity. Journal of Neurosurgery . 1990; 72 393-402
90 Muller-Schwefe GR , Penn R D. Physostigmine in the treatment of intrathecal baclofen overdose: report of three cases. Journal of Neurosurgery . 1989; 71 273-275
91 Saltuari L , Baumgartner H , Kofler M . Failure of physostigmine in treatment of acute severe intrathecal baclofen intoxication. New England Journal of Medicine . 1990; 322 1533-1534
92 Delhaas E M, Brouwers J R. Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature. International Journal of Clinical Pharmacology, Therapy, & Toxicology . 1991; 29 274-280
93 Kofler M , Arturo L A. Prolonged seizure activity after baclofen withdrawal. Neurology . 1992; 42 697-698
94 Mandac B R, Hurvitz E A, Nelson V S. Hyperthermia associated with baclofen withdrawal and increased spasticity. Archives of Physical Medicine and Rehabilitation . 1993; 74 96-97
95 Reeves R K, Stolp-Smith K A, Christopherson M W. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Archives of Physical Medicine & Rehabilitation . 1998; 79 353-356
96 Siegfried R N, Jacobson L , Chabal C . Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. Anesthesiology . 1992; 77 1048-1050
97 Khorasani A , Peruzzi W T. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesthesia & Analgesia . 1995; 80 1054-1056
98 Gardner B , Jamous A , Teddy P . Intrathecal baclofen: a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems. Paraplegia . 1995; 33 551-554
99 Penn R D, York M M, Paice J A. Catheter systems for intrathecal drug delivery. Journal of Neurosurgery . 1995; 83 215-217
100 Müller H . Treatment of severe spasticity: results of a multicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system. In: Lakke JPWF, Delhaas EM, Rutgers AWF, eds. Parenteral Drug Therapy in Spasticity and Parkinson's Disease. Lancaster: Parthenon 1992: 103-113
101 Hugenholtz H D, Nelson R F, Dehoux E . Intrathecal baclofen: the importance of catheter position. Canadian Journal of Neurological Sciences . 1993; 20 165-167